Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Inhibition of the development of chronic experimental autoimmune encephalomyelitis by laquinimod (ABR-215062) in IFN-beta k.o. and wild type mice.
Bag3-Induced Autophagy Is Associated with Degradation of JCV Oncoprotein, T-Ag.
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis.
Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.
Central and Peripheral Nervous System Demyelination Following Mycoplasma Pneumonia Infection With Review of Literature.
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.
A randomized trial of stress management for the prevention of new brain lesions in MS.
Minocycline in Clinically Isolated Syndromes (CIS) and Early Single Relapse Multiple Sclerosis (MS)
Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis.
The role of tumour necrosis factor α in the pathogenesis of multiple sclerosis, and pentoxifylline as a possible pharmacotherapeutic intervention.
Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis.
Safety and efficacy extension study of daclizumab high yield process (DAC HYP) to treat relapsing remitting multiple sclerosis
Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System.
The attributable burden of panic disorder in the impairment of quality of life in a national survey in Italy.
A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod
New Disease-Modifying Therapies and New Challenges for MS.
DYNACIN (MINOCYCLINE)
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases.
Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis.
Risk of vascular disease in patients with multiple sclerosis: a review.
Contribution of imaging to the diagnosis of optic neuropathies.
How Natalizumab Binds and Antagonizes α4 Integrins.
Reductions in neuronal peroxisomes in multiple sclerosis grey matter.

Pages